ULA XUE

Ula joined Delos in 2017, prior to which she was a senior associate at Olympus Capital Asia, focusing on growth opportunities investment in Greater China. Ula has over 10 years of experience in investment banking, private equity and venture capital. She was previously an investment banker at Goldman Sachs and JP Morgan. Ula is currently a Board Representative for Tanvex BioPharma, Inc. (Taiwan Stock Exchange listed, Symbol: 6541), and was previously a Board observer for Luqa Pharmaceuticals (acquired by China Medical System, HKEx: 867).

Ula obtained her Bachelor’s degree from the Hong Kong University of Science and Technology with a major in Global Business and Finance.